Proline Analogs as ligands for cannabinoid receptors for the treatment of pain

Details for Australian Patent Application No. 2009203549 (hide)

Owner Purdue Pharma L.P.

Inventors Shao, Bin; Yao, Jiangchao

Agent FB Rice

Pub. Number AU-A-2009203549

PCT Pub. Number WO2009/087564

Priority 61/010,447 08.01.08 US

Filing date 8 January 2009

Wipo publication date 16 July 2009

International Classifications

C07D 207/48 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/401 (2006.01) - Proline

A61K 31/4025 (2006.01) - not condensed and containing further heterocyclic rings, e.g. cromakalim

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

8 July 2010 PCT application entered the National Phase

  PCT publication WO2009/087564 Priority application(s): WO2009/087564

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009203557-Unitary withdrawal spike unit suitable for factory fitting

2009203545-Clottable concentrate of platelet growth factors and preparation method thereof